Press Releases

April 18, 2023 | 3rd Party Observation

Universitätsspital Basel (University Hospital of Basel) Patent Application, Porta Sophia Files Third Party Observation

Patent Application: Co-Treatment of Antidepressant and Psychedelic

View Press Release

April 12, 2023 | 3rd Party Submission

CaaMTech U.S. Patent Application, Porta Sophia Files Third Party Submission

Patent Application: Purified Ibogaine and Ibogaine Derivatives for the Treatment of Addiction and Depression

View Press Release

April 10, 2023 | 3rd Party Submission

Mind Medicine, Inc. U.S. Patent Application, Porta Sophia Files Third Party Submission

Patent Application: Psychedelics Taken with 5-HT2A Antagonists to Control Psychedelic Trip Duration

View Press Release

March 29, 2023 | 3rd Party Submission

Universitätsspital Basel (University Hospital of Basel) Application, Porta Sophia Files Third Party Submission

Patent Application: Co-Treatment of Antidepressant and Psychedelic

View Press Release

March 16, 2023 | Press Release | Claims Rejection

All Claims Rejected for Universitätsspital Basel US Patent Application Describing Mescaline and Analogs to Treat Medical Conditions

USPTO directly cites prior art included in Porta Sophia's third-party preissuance submission in establishing application's lack of novelty and non-obviousness

View Press Release

March 10, 2023 | Press Release | Claims Rejection

All Claims Rejected for University of Maryland, Baltimore US Patent Application Describing Psilocybin and Ketanserin or Ritanserin to Treat Depression

USPTO directly cites prior art included in Porta Sophia's third-party preissuance submission in establishing application's lack of novelty and non-obviousness

View Press Release

March 10, 2023 | 3rd Party Submission

Journey Colab Corp International Patent Application, Porta Sophia Files Third Party Submission

Patent Application: Mescaline for Treatment of Substance Use Disorders

View Press Release

March 6, 2023 | 3rd Party Observation

Porta Sophia Files Third-Party Preissuance Submission for Turtle Bear Holdings, LLC U.S. Patent Application

Patent Application: Psychedelics Combined With Lion's Mane Mushrooms and Monoamine Oxidase Inhibitors To Modulate Inflammation Caused by Infection

View Press Release

February 23, 2023 | Press Release | Claims Rejection

All Claims Rejected for Universitätsspital Basel US Patent Application Describing MDMA to Enhance Emotional Effects of Psychedelics

USPTO directly cites prior art included in Porta Sophia's third-party preissuance submission in establishing application's lack of novelty and non-obviousness

View Press Release

February 23, 2023 | 3rd Party Submission

Mind Medicine, Inc U.S. Patent Application Two, "PSYCHDELICS FOR TREATMENT OF PAIN," Porta Sophia Files Third Party Submission

Psychedelic prior art library presents eight documents challenging patentability of all claims

View Press Release

February 23, 2023 | 3rd Party Submission

Mind Medicine, Inc U.S. Patent Application One, "PSYCHDELICS FOR TREATMENT OF PAIN," Porta Sophia Files Third Party Submission

Psychedelic prior art library presents seven documents challenging patentability of all claims

View Press Release

February 23, 2023 | 3rd Party Observation

Mind Medicine, Inc International Patent Application, Porta Sophia Files Third Party Observation

Psychedelic prior art library presents four documents challenging patentability of 23 application claims

View Press Release

February 17, 2023 | 3rd Party Submission

University of Maryland, Baltimore U.S. Patent Application, Porta Sophia Files Third Party Submission

Psychedelic prior art library presents three documents challenging patentability of all claims

View Press Release

January 30, 2023 | Press Release

Porta Sophia Responds to USPTO Request for Comments on Initiatives to Ensure the Robustness and Reliability of Patent Rights

View Press Release

January 23, 2023 | 3rd Party Observation

Universitätsspital Basel Patent Application, Porta Sophia Files Third Party Observation

Psychedelic prior art library presents 14 documents challenging patentability of all application claims

View Press Release

January 20, 2023 | 3rd Party Submission

University of Basel Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 13 documents challenging patentability of all application claims

View Press Release

January 12, 2023 | 3rd Party Submission

Arbormentis LLC U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 26 documents challenging patentability of all claims

View Press Release

January 6, 2023 | 3rd Party Submission

Mind Medicine Inc. U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents seven documents challenging patentability of all claims

View Press Release

December 15, 2022 | 3rd Party Submission

Turtle Bear Holdings U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents five documents challenging patentability of all claims

View Press Release

December 14, 2022 | Press Release

All Claims of Pharma America Holding US Patent Application Describing MDMA in Combination with Viagra® Rejected

USPTO directly cites prior art included in Porta Sophia's third-party preissuance submission in establishing application's lack of novelty

View Press Release

November 23, 2022 | 3rd Party Submission

Shawn Joseph U.S. Patent Application, Porta Sophia Files Third-Party Observation

Psychedelic prior art library presents 10 documents challenging patentability of all application claims

View Press Release

November 23, 2022 | 3rd Party Observation

Mynd Life Sciences International Patent Application, Porta Sophia Files Third-Party Observation

Psychedelic prior art library presents 2 documents challenging patentability of all application claims

View Press Release

November 22, 2022 | 3rd Party Observation

Compass Pathfinder Limited Patent Application, Porta Sophia Files Third-Party Observation

Psychedelic prior art library presents 4 documents challenging patentability of 38 of 52 claims

View Press Release

November 1, 2022 | 3rd Party Observation

GoodCap Pharmaceuticals Patent Application, Porta Sophia Files Third-Party Observation

Psychedelic prior art library presents 16 documents challenging patentability of all application claims

View Press Release

October 5, 2022 | Press Release

Yale Patent Application Claims Rejected as Unpatentable Based on References Submitted to the USPTO by Porta Sophia

View Press Release

August 25, 2022 | Press Release

COMPASS Pathways Amends Claims of US Patent Application Describing Psilocybin for the Treatment of Depression

Psychedelic drug company submits revised, narrower set of claims five months after Porta Sophia’s third-party preissuance submission challenged patentability

View Press Release

August 23, 2022 | 3rd Party Observation

Wesana Health International Patent Application, Porta Sophia Files Third-Party Observation

Psychedelic prior art library presents 5 documents challenging patentability of 105 claims

View Press Release

July 22, 2022 | 3rd Party Submission

CaaMTech U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 9 documents challenging patentability of all claims

View Press Release

July 22, 2022 | 3rd Party Submission

Pharma America Holding Inc. U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 9 documents challenging patentability of all claims

View Press Release

July 22, 2022 | 3rd Party Submission

Diamond Therapeutics Inc. U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 8 documents challenging patentability of all claims

View Press Release

June 16, 2022 | 3rd Party Submission

GH Research Ireland Limited U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 23 documents challenging patentability of all claims

View Press Release

June 7, 2022 | 3rd Party Submission

Turtle Bear Holdings LLC U.S. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 8 documents challenging patentability of all claims

View Press Release

April 14, 2022 | 3rd Party Submission

University of Basel Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 21 documents challenging patentability of all claims of University of Basel application

View Press Release

April 5, 2022 | 3rd Party Submission

Pike Therapeutics Inc. Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 23 documents challenging patentability of all claims of Pike Therapeutics Inc. application

View Press Release

March 9, 2022 | 3rd Party Submission

COMPASS Pathways Patent Application, Porta Sophia Files Third-Party Preissuance Submission

Psychedelic prior art library presents 39 documents challenging patentability of all claims of COMPASS Pathways application

View Press Release

February 23, 2022 | 3rd Party Submission

Porta Sophia Files Third-Party Preissuance Submission For Patent Application Filed By Yale University and the US Department of Veterans Affairs

Psychedelic prior art library presents five documents challenging patentability of all claims of the application filed by co-applicants Yale University and The United States of America as represented by the Department of Veterans Affairs

View Press Release

December 16, 2021 | 3rd Party Submission

CaaMTech Inc. Cancels All Claims of US Patent Application Describing Serotonergic Drug Combinations

Psychedelic drug company submits revised, narrower set of claims within a month of Porta Sophia’s third-party preissuance submission challenging patentability

View Press Release

November 19, 2021 | 3rd Party Submission

Porta Sophia Files Third-Party Preissuance Submission For CaaMTech Inc. Patent Application

Psychedelic prior art library presents 18 documents challenging patentability of all claims of CaaMTech Inc. application

View Press Release
Learn about the status and impact of Porta Sophia's third party submissions and observations.

View Our Summary Chart